TAK

Q: What is the price of Takeda Pharmaceutical (TAK) today?

The current price of Takeda Pharmaceutical (TAK) is $ 17.82, representing a 26.73% gain over the past year. The stock began the year trading around $ 15.59 and is currently priced at $ 17.82. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Takeda Pharmaceutical (TAK) pay dividends?

Takeda Pharmaceutical (TAK) did not pay dividends over the past year.

Takeda Pharmaceutical Co. Ltd.

Price

$ 17.82

return (12m)

26.73%

p/e

74.74

p/bv

1.15

DIVIDEND YIELD

3.71%

TAK price

TAK

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TAK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.06%

3 months

10.34%

1 year

26.73%

2 years

47.07%

5 years

30.49%

10 years

9.94%

Fundamentals TAK

review the fundamentals of Takeda Pharmaceutical shares

P/E

74.74

Sector: -2.29 Industry: 10.92

P/S (PSR)

1.88

Sector: 1.99 Industry: 1.60

P/BV

1.15

Sector: 2.18 Industry: 3.07

DIVIDEND YIELD (DY)

3.71%

Sector: - Industry: 0.01%

ROA

0.76%

Sector: -26.05% Industry: 2.70%

ROE

1.54%

Sector: -29.81% Industry: 5.25%

ROIC

3.71%

Sector: -416.93% Industry: -2.27%

NET MARGIN

2.52%

Sector: -28.23% Industry: 2.71%

GROSS MARGIN

65.32%

Sector: 44.66% Industry: 28.76%

OPERATING MARGIN

7.77%

Sector: -23.34% Industry: 1.39%

EV/EBITDA

6.23

Sector: -0.62 Industry: 4.03

EV/EBIT

14.78

Sector: -1.80 Industry: 2.44

PRICE-TO-ASSETS

0.57

Sector: 1.17 Industry: 1.44

BVPS

15.53

Sector: 3.79 Industry: 11.41

EPS

0.24

Sector: -0.90 Industry: 1.09

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

0.50

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

-0.91%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-28.36%

Sector: - Industry: -

FAIR VALUE OF Takeda Pharmaceutical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 17.82

Fair Value

$ 0.00

Upside/Downside Return potential.

-48.61%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TAK

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TAK Historical Dividends

current DY: 3.71%

5-year average DY: 4.94%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/30/2025	12/11/2025	0,32210000
Dividends	03/31/2025	07/07/2025	0,33900000
Dividends	09/30/2024	12/12/2024	0,33300000
Dividends	03/28/2024	07/08/2024	0,29220000
Dividends	09/29/2023	12/11/2023	0,31910000
Dividends	03/31/2023	07/10/2023	0,26900000
Dividends	09/30/2022	12/12/2022	0,30120000
Dividends	03/31/2022	07/11/2022	0,33010000
Dividends	09/30/2021	12/13/2021	0,39690000
Dividends	03/31/2021	07/12/2021	0,40660000
Dividends	09/30/2020	12/11/2020	0,43050000
Dividends	03/31/2020	07/06/2020	0,41900000
Dividends	09/30/2019	12/12/2019	0,41110000
Dividends	03/29/2019	07/10/2019	0,41720000
Dividends	09/28/2018	12/13/2018	0,39550000
Dividends	03/29/2018	07/09/2018	0,40640000
Dividends	09/29/2017	12/11/2017	0,39950000
Dividends	03/31/2017	07/10/2017	0,39890000
Dividends	09/30/2016	12/12/2016	0,39240000
Dividends	03/31/2016	07/11/2016	0,43700000
Dividends	09/30/2015	12/11/2015	0,36530000
Dividends	03/31/2015	07/09/2015	0,36530000
Dividends	09/29/2014	12/11/2014	0,37830000
Dividends	03/28/2014	07/10/2014	0,44370000
Dividends	09/27/2013	12/12/2013	0,43700000
Dividends	03/28/2013	07/08/2013	0,45710000
Dividends	09/27/2012	12/13/2012	0,54600000
Dividends	03/29/2012	07/09/2012	0,56380000
Dividends	09/29/2011	12/12/2011	0,57860000
Dividends	03/30/2011	07/07/2011	0,55580000
Dividends	09/29/2010	12/13/2010	0,53320000
Dividends	09/29/2009	12/15/2009	0,51780000
Dividends	03/30/2009	07/14/2009	0,48180000
Dividends	09/29/2008	12/16/2008	0,46810000

ABOUT Takeda Pharmaceutical

Takeda Pharmaceutical Co. Ltd.

Average Investor10 user rating

4.0 (15 people)

United States

101 years

Founded: 1925

2010

Time since IPO - 16 years

47.495

Employees

Takeda Pharmaceutical Co. Ltd. (United States) is listed on the NYSE and has a market capitalization of $56.26 Billions, with shareholders equity totaling $49.03 Billions.

The company employs approximately 47.495 people and operates in the Health sector, within the Main Medications industry.

Over the past 12 months, Takeda Pharmaceutical Co. Ltd. reported $29.90 Billions in revenue, generating net income of $752.76 Millions.

Key financial metrics include a P/E ratio of 74.74, a price-to-book (P/B) ratio of 1.15, and a trailing twelve-month dividend yield of 3.71%.

The company trades under the ticker TAK.

Market cap

$ 56.26 Billions

Net worth

$ 49.03 Billions

$ 49,027,290,000.00

Assets

$ 98.83 Billions

$ 98,828,040,000.00

Total Shares Outstanding

3.16 Billions

3,157,000,000

Average Daily Trading Volume

$ 2.81 Millions

$ 2,809,188.00

Sector

Health

Industry

Main Medications

TAK

revenue by Business Segment Takeda Pharmaceutical

Revenue by Region Takeda Pharmaceutical

TAK revenue and profits

Financial Results TAK

DRAG THE FRAME TO SEE MORE DATA

TAK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,29% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 927.03 12,84% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25